- Home
- KYTX vs DOUG Comparison
KYTX vs DOUG Comparison
Compare KYTX & DOUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYTX
- DOUG
- Stock Information
- Founded
- KYTX 2018
- DOUG 1911
- Country
- KYTX United States
- DOUG United States
- Employees
- KYTX N/A
- DOUG N/A
- Industry
- KYTX
- DOUG Building operators
- Sector
- KYTX
- DOUG Real Estate
- Exchange
- KYTX NYSE
- DOUG Nasdaq
- Market Cap
- KYTX 166.4M
- DOUG 142.2M
- IPO Year
- KYTX 2024
- DOUG N/A
- Fundamental
- Price
- KYTX $3.36
- DOUG $1.78
- Analyst Decision
- KYTX Buy
- DOUG
- Analyst Count
- KYTX 5
- DOUG 0
- Target Price
- KYTX $23.20
- DOUG N/A
- AVG Volume (30 Days)
- KYTX 308.0K
- DOUG 1.0M
- Earning Date
- KYTX 02-12-2025
- DOUG 02-27-2025
- Dividend Yield
- KYTX N/A
- DOUG N/A
- EPS Growth
- KYTX N/A
- DOUG N/A
- EPS
- KYTX N/A
- DOUG N/A
- Revenue
- KYTX N/A
- DOUG $966,442,000.00
- Revenue This Year
- KYTX N/A
- DOUG $5.28
- Revenue Next Year
- KYTX N/A
- DOUG $16.40
- P/E Ratio
- KYTX N/A
- DOUG N/A
- Revenue Growth
- KYTX N/A
- DOUG 1.86
- 52 Week Low
- KYTX $3.22
- DOUG $1.00
- 52 Week High
- KYTX $30.60
- DOUG $2.98
- Technical
- Relative Strength Index (RSI)
- KYTX 37.34
- DOUG 51.03
- Support Level
- KYTX $3.22
- DOUG $1.49
- Resistance Level
- KYTX $3.53
- DOUG $1.89
- Average True Range (ATR)
- KYTX 0.25
- DOUG 0.11
- MACD
- KYTX 0.00
- DOUG 0.04
- Stochastic Oscillator
- KYTX 13.46
- DOUG 73.42
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.
About DOUG Douglas Elliman Inc.
Douglas Elliman Inc is a real estate company. It offers sales, rentals, and new development to mortgages and title insurance, among other services related to real estate. Business is engaged in two operating segments Real Estate Brokerage and Corporate and other. The firm generates income from Commission and other brokerage revenue from existing home sales, Commission and other brokerage income from development marketing, Property management revenue and Title fees.